Cowen Financial Products LLC 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-02 12:28 pm Sale |
2023-12-29 | 13G | Jounce Therapeutics, Inc. JNCE |
Cowen Financial Products LLC | 0 0.000% |
-3,647,430 (Position Closed) |
Filing |
| 2023-01-23 3:48 pm Purchase |
2022-12-30 | 13G | Jounce Therapeutics, Inc. JNCE |
Cowen Financial Products LLC | 3,647,430 7.050% |
567,078 (+18.41%) |
Filing |
| 2022-04-22 10:54 am Purchase |
2022-04-21 | 13G | Jounce Therapeutics, Inc. JNCE |
Cowen Financial Products LLC | 3,080,352 5.960% |
3,080,352 (New Position) |
Filing |